百奥赛图将于9月24日接受上交所上市委审核。百奥赛图(北京)医药科技股份有限公司是一家创新药临床前CRO及生物技术公司。主营业务:为创新药企业提供 抗体药物发现及临床前研发服务,具体包括创新模式动物销售、临床前药理药效评价服 务及抗体开发等。主要产品及服务:一、基因编辑服务;二、创新模式动物销售;三、临床前药理药效评价服务;四抗体开发;五、新药自主及合作研发。证监会行业分类:C2761 生物药品...
Source Link百奥赛图将于9月24日接受上交所上市委审核。百奥赛图(北京)医药科技股份有限公司是一家创新药临床前CRO及生物技术公司。主营业务:为创新药企业提供 抗体药物发现及临床前研发服务,具体包括创新模式动物销售、临床前药理药效评价服 务及抗体开发等。主要产品及服务:一、基因编辑服务;二、创新模式动物销售;三、临床前药理药效评价服务;四抗体开发;五、新药自主及合作研发。证监会行业分类:C2761 生物药品...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.